Min Gyu Lee, Ph.D.
Dept. of Molecular & Cellular Oncology
The University of Texas MD Anderson Cancer Center
Dr. Lee has studied the roles of epigenetic modulators in regulating tumorigenesis, metastasis, and stem cell characteristics. The pioneering research accomplishments by Dr. Lee and his colleagues include: 1) Identification of essential factors and inhibitors for the first-known histone demethylase LSD1; 2) Discovery of two families of Jumonji C-containing histone demethylases; 3) Identification of several histone methylation modifiers as a novel stemness or differentiation factor; 4) Characterization of new tumor-suppressive histone methylation modifiers and readers; and 5)Identification of new oncogenic histone methylation modifiers and readers. Dr. Lee earned his PhD degree in The Johns Hopkins Medical School and was a Postdoctoral fellow in the Wistar Institute. He is also a member of the Center for Cancer Epigenetics in UT MD Anderson Cancer Center. He has served as a reviewer for NIH grant applications, other national and international grant applications, and multiple scientific journals.